Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

swissinfo.ch - Jessica Davis Plüss (text) Kai Reusser (visuals) - AI's next pharma challenge: tackling costly and risky clinical trials
AI's next pharma challenge: tackling costly and risky clinical trials
www.swissinfo.ch

Ask a pharmaceutical company about the current approach to clinical trials and you're likely to hear a chorus of complaints about a broken and dysfunctional system. It takes on average at least a decade and roughlyExternal link $1-2 billion (CHF790…

thedrinksbusiness.com - Amelie Maurice-Jones - South Korean pharma firm plots pivot into liquor
South Korean pharma firm plots pivot into liquor
The Drinks Business

From Suntory to BrewDog, a flurry of booze brands have leapt into the health sector in a bid to boost revenue. Now, in an uno-reverse, Korean pharmaceutical firm Kyung Nam Pharm, has reportedly set its sights on the spirits market. In recent times…

thehindubusinessline.com - Natco Pharma's Q4 net down 34% at ₹269 cr
Natco Pharma's Q4 net down 34% at ₹269 cr
BusinessLine

Natco Pharma's consolidated net profit declined 34 percent at ₹269 crore in the fourth quarter of last financial year ended March 31, 2026 compared to ₹406 crore in the corresponding quarter previous year. The total revenue of the…

tvtechnology.com - Tom Butts - TV Pharma Ads Are Getting Longer, According to VAB
TV Pharma Ads Are Getting Longer, According to VAB
TV Tech

NEW YORK— If you think the ubiquitous television commercials for pharmaceuticals are already too long, a new report from the Video Advertising Bureau confirms your suspicions. According to the report pharmaceutical companies have increased…

marketbeat.com - Legal & General Group Plc Has $119.32 Million Stake in Royalty Pharma PLC $RPRX
Legal & General Group Plc Has $119.32 Million Stake in Royalty Pharma PLC $RPRX
MarketBeat

Legal & General Group Plc boosted its stake in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 9.4% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned…

wsj.com - Health Care Roundup: Market Talk
Health Care Roundup: Market Talk
Wall Street Journal

The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET. 0815 GMT – Bayer's pharmaceutical business has good momentum but faces risks over the medium term from…

marketbeat.com - JTC Employer Solutions Trustee Ltd Purchases Shares of 75,500 NewAmsterdam Pharma Company N.V. $NAMS
JTC Employer Solutions Trustee Ltd Purchases Shares of 75,500 NewAmsterdam Pharma Company N.V. $NAMS
MarketBeat

JTC Employer Solutions Trustee Ltd purchased a new stake in shares of NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Free Report) during the 4th quarter, according to the company in its most recent filing with the SEC. The fund purchased 75,500…

marketbeat.com - United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund Purchases Shares of 234,551 Royalty Pharma PLC $RPRX
United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund Purchases Shares of 234,551 Royalty Pharma PLC $RPRX
MarketBeat

United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund purchased a new stake in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) during the fourth quarter, according to the company in its most…

news-medical.net - Half of clinical trial professionals cite trust and regulatory gaps as barrier to AI adoption, Pistoia Alliance poll finds
Half of clinical trial professionals cite trust and regulatory gaps as barrier to AI adoption, Pistoia Alliance poll finds
News-Medical

The Pistoia Alliance, a global, not-for-profit alliance that advocates for greater collaboration in life sciences R&D, has released new poll data showing trust and regulatory uncertainty are the biggest barriers to AI adoption in clinical trials…

afr.com - Bonnie Campbell - Billionaire Dennis Bastas pays record $136.1m for Toorak mega estate
Billionaire Dennis Bastas pays record $136.1m for Toorak mega estate
Australian Financial Review

Pharma billionaire Dennis Bastas and his wife Gina paid a total of $136.1 million to create Australia's most expensive estate through a two-title deal that takes in both the landmark Toorak Italianate mansion Coonac and an adjoining 1950s apartment…

cnbc.com - Justina Lee - Innovent Biologics shares rise 10% after pact with Pfizer of up to $10.5 billion
Innovent Biologics shares rise 10% after pact with Pfizer of up to $10.5 billion
CNBC

The partnership includes licensing, co-development, and co-commercialization opportunities across a diverse portfolio of antibody-drug conjugates. Innovent will will co-commercialize with Pfizer in the U.S. and Europe and share profits but retain…

seekingalpha.com - Wall Street Breakfast - Wall Street Breakfast Podcast: New Glenn Ignites Concern
Wall Street Breakfast Podcast: New Glenn Ignites Concern
Seeking Alpha

Listen below or on the go via Apple Podcasts and Spotify Blue Origin's (BORGN) New Glenn rocket explodes on launchpad. (00:14) Tesla (TSLA) Robotaxi fleet in Texas is less than one-tenth of Waymo's. (01:03) Costco (COST) sees record fuel sales…

theguardian.com - Guardian staff reporter - She criticizes capitalism - and also gives investing advice: 'It's better to participate than working until we die'
She criticizes capitalism - and also gives investing advice: 'It's better to participate than working until we die'
The Guardian

Amanda Holden is, in her words, an “ex-finance bro”. She landed a job in investment management right out of college and was earning a six-figure income by her early 20s. But after five years of “letting grown men scream at me…

fool.com - Ben Gran - This Global ETF Beat the Nasdaq-100 for Most of the Past Year. Should You Buy It?
This Global ETF Beat the Nasdaq-100 for Most of the Past Year. Should You Buy It?
The Motley Fool

Usually, tech stocks are the best place to put your money, right? Not always. International dividend stocks have been strong lately. Until mid-April, the Vanguard International High Dividend Yield ETF (VYMI +0.40%) had outperformed the Invesco QQQ…

newswire.ca - Daiichi Sankyo - Daiichi Sankyo Concludes pCPA Letter of Intent for Vanflyta in Newly Diagnosed FLT3-ITD Positive AML
Daiichi Sankyo Concludes pCPA Letter of Intent for Vanflyta in Newly Diagnosed FLT3-ITD Positive AML
CNW

Completion of pan-Canadian Pharmaceutical Alliance (pCPA) negotiations enables public reimbursement of Vanflyta across Canada, with Quebec reimbursing Vanflyta in May 2026 Reimbursement includes use across induction, consolidation and maintenance…

Receive a Daily briefing on Pharma Industry News

Get Started